The Dublin Tech Summit (DTS) is an international technology conference held in Dublin, Ireland. The first summit took place on 15 and 16 February 2017, at the Convention Centre Dublin in the city’s “Silicon Docks”.
The summit aims to run annually, and to attract more than 10,000 attendees, including influential speakers, startups, exhibitors, sponsors and investors, covering eight main themes: business, Internet of Things, marketing, FinTech, MedTech, Big Data & FashionTech.
The BIO International Convention attracts 16,000+ attendees from 5,000+ companies including the leading Biotech and pharma companies, top 20 CROs and CMOs, more than 300 academic institutions including major research labs and government agencies, as well as leading consultants and service companies.
The expansive BIO Exhibition is packed with the latest trends, technology, companies, and breakthrough ideas in BioTech and pharma. They have over 1,800 exhibiting companies and delegations from 74 countries who host a variety of activities and provide opportunities to learn more about how they can help fuel your next big breakthrough.
The BIO exhibition is the hub of Bio one-on-one Partnering activity with 40,000+ meetings, 1,800 exhibitors and the centrally located BIO Business Forum.
Company presentations are the perfect way to increase visibility and attract more partners at the BIO International Convention. Pitch your company’s story, pipelines, and objectives to a global audience representing over 69 countries. Gain access to business development executives, investors, research analysts, policy makers, and medias.
As the world’s largest biotechnology event, the BIO International Convention provides several specialized opportunities geared towards start-up and emerging companies. The Startup Stadium was designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees. This area in the BIO exhibition provides and exciting and interactive experience where investors provide live feedback and judge 6 minutes pitches presented by start-up biotech companies.